“Background Campylobacter jeuni is a foodborne pathogen an

“Background Campylobacter jeuni is a foodborne pathogen and a major cause of bacterial diarrhoea worldwide [1], yet its pathogenicity is poorly understood. The virulence attributes of C. jejuni include cell culture adherence and invasion, flagella and motility, iron-acquisition capability and toxin production [2]. Known toxins include a cytolethal distending toxin (CDT), a cholera toxin-like enterotoxin (CTLT), and a number

of cytotoxins [3]. However, only the genes encoding the CDT have been identified so far [4]. There is uncertainty on the production of CTLT by C. jejuni. Our recent work indicated that the major outer membrane protein (MOMP-PorA) selleck chemical of C. jejuni cross-reacts with cholera toxin (CT) which would likely have misled investigators that C. jejuni produces a CTLT [5]. It is believed Proteasome purification that the cytotoxin(s) may

mediate inflammatory diarrhoea that is JNK-IN-8 clinical trial characteristic of infection in individuals in developed countries [6]. One major cytotoxin is a protein-sized molecule that is active on a number of cell lines such as HeLa and Chinese hamster ovary (CHO), but is inactive on Vero cells [3]. A previous report claimed that the MOMP of C. jejuni was responsible for cytotoxicity on mammalian cells [7]. However, in our previous work, the expressed PorA protein from the cloned gene of a cytotoxin-producing C. jejuni strain did not have cytotoxic activity for mammalian cells and was also devoid of diarrhoeagenic activity in an animal model of infection [8]. In our continuing efforts to characterise this unknown cytotoxin, we investigated a series of chromatographic methods to enrich the cytotoxin from a cytotoxic C. jejuni

strain. Using previously established methods of detection as well as further modifications to these protocols, we have attempted to isolate and purify the cytotoxin. The results of further characterisation studies confirm that the likely cytotoxin candidate is a protein. The results are reported in this communication. Results and discussion Cytotoxicity assay In this study, we have developed a methodology to detect and purify the toxin potentially involved in the diarrhoeagenic activity of C. jejuni, C31 strain. To detect and quantify cytotoxic activity during purification, we used an activity assay based on the lethal effects of the toxin on CHO cells. The TCID50 Demeclocycline of C31 strain for CHO cells was similar at 1–2 μg for a freshly prepared protein extract as well as a reconstituted form of the lyophilised extract as estimated by the visual method by direct microscopic observation of cytotoxic effect on cells [8] or by the indirect methyl thiazol tetrazolium (MTT) method by spectrophotometric measurement of formazin [9]. The cytotoxic effect of C31 toxin on CHO cells is shown in Figure 1. The extract was devoid of any cytotoxic effect when tested on Vero cells as described previously [8]. Figure 1 Effect of C. jejuni crude protein extract on CHO cells.

(b) Experimental I-V data of HRS at higher temperatures (140 to 2

(b) Experimental I-V data of HRS at higher temperatures (140 to 200 K). The good linear relationship between ln(I/V) and √V indicates that the electronic behavior of HRS can be predicted by utilizing Poole-Frenkel effect. Y coordinates of line were added with a constant to separate each line. https://www.selleckchem.com/products/ly2874455.html The V 1/2 in x-axis means √V in the (b), and it shows the good linear relationship between ln(I/V) and V 1/2 in the temperature range 140 to 200 K obviously. Conclusions The conductive filament rupture in RRAM RESET process can be attributed not only to joule heat generated by internal current flow through a filament

but also to the charge trap/detrapping effect. A new conduction mode is discussed from hopping conduction to Frenkel-Poole conduction with elevated temperature. This finding will help us understand the physical mechanism

of resistive switching deeply in RRAM application. Authors’ information PZ received his BS degree in Physics Geneticin and his PhD degree in optics from Fudan University, Shanghai, China, in 2000 and 2005, respectively. He is currently an associate professor in the School of Microelectronics, Fudan University. His Quisinostat chemical structure research interests include fabrication and characterization of advanced metal-oxide-semiconductor field-effect transistors, advanced memory devices, and graphene device. LY received his BS degree and the MS degree in microelectronics from Fudan University, Shanghai, China, in 2009 and 2012, respectively. He is currently a 28-nm Graphics Design Engineer in Huali Microelectronics Corporation, Shanghai. His research interests include low-power circuit, memory and device design, and fabrication for the cutting edge integrated circuit technology. QQS received his BS degree in Physics and his MS degree in microelectronics and solid state electronics from Fudan University, Shanghai, China, in 2004 and 2009, respectively. He is currently an associate professor in the School of Microelectronics, Fudan University. His research Buspirone HCl interests include fabrication and characterization

of advanced metal-oxide-semiconductor field-effect transistors, mainly high-k dielectric-based devices. He is also interested in design, fabrication, and characterization of advanced memory devices, such as resistive switching memory devices and Flash. PFW received his BS and MS degrees from Fudan University, Shanghai, China, in 1998 and 2001, respectively, and his Ph.D. degree from the Technical University of Munich, München, Germany, in 2003. Until 2004, he was with the Memory Division of the Infineon Technologies in Germany on the development and the process integration of novel memory devices. Since 2009, he has been a professor ins Fudan University. His research interests include design and fabrication of semiconductor devices and development of semiconductor fabrication technologies such as high-k gate dielectrics and copper/low-k integration.

The region of the as-grown LBZA diffractogram corresponding to tw

The region of the as-grown LBZA diffractogram corresponding to two theta angles greater than 10° has been magnified 10 times. Figure 4 shows SEM images of LBZA NSs after annealing at 200°C, 400°C and 800°C. The 200°C image clearly shows interconnected NPs within the NSs and increasing temperature results in a size increase of the ZnO NPs, confirming the XRD data. The results of the size analysis are given in Table 1 and show that the crystallite size increases from 15.8 nm at 200°C to 104 nm at 1,000°C. In addition, sintering of the NPs is observed at 600°C (Figure 4) After annealing at 800°C, the sintering process intensifies.

The NSs keep their shape mTOR target and their structures reasonably constant even after the 1,000°C anneal, similar to previous results for nanobelts [8]. The thickness of the NSs was not significantly altered by the annealing process. Figure 4 SEM images from annealed LBZA NSs at 200°C, 400°C, 600°C and 800°C. HMPL-504 nmr Scale bar 2 μm. Insets: detail of the nanocrystals, scale bar 200 nm. Table 1 SEM size measurement of the crystallite size for ZnO NSs evolved from LBZA

NSs annealed at different temperatures and their standard deviation Temperature (°C) 200 400 600 800 1,000 Average size (nm) 15.8 23.1 37.4 70.3 104 Standard deviation (nm) 3.2 9.34 14.66 22.6 38.5 Figure 5 shows the PL spectra acquired from ZnO NSs produced by annealing of LBZA NSs at various temperatures in air. The spectra show the narrow near band edge (NBE) peak at 380 nm and the broad visible band typical of ZnO, associated with deep level emission (DLE). The DLE band is centered around 630 nm for the NSs produced

at 400°C, resulting in a red orange emission, which is significantly red-shifted compared to the green/yellow emission typical of single crystal ZnO nanostructures such as nanorods [15] and tetrapods [16]. After annealing at 600°C and 800°C, the band broadens and the orange contribution of the visible band becomes more intense. Annealing at 1,000°C resulted in a predominantly green visible band. The DLE contribution is conventionally attributed to Protein Tyrosine Kinase inhibitor oxygen vacancies and other bulk lattice defects, despite evidence pointing to surface defects for nanostructures [17, 18]. Our results show that the NBE to Molecular motor DLE band ratios, calculated from the area under the PL spectra, are 0.161 at 400°C, 0.011 at 600°C, 0.009 at 800°C and 0.024 at 1,000°C. As the nanoparticle size within the NSs increases with temperature, the surface-to-volume ratio decreases, therefore indicating that the DLE is not caused by surface effects in our case. It would instead point towards a decrease in optical crystal quality at annealing temperatures higher than 400°C. Hsieh et al. [19] have reported a large DLE band for their thin ZnO films after annealing at 900°C in air compared to annealing in vacuum or pure oxygen. They attributed the DLE to increased oxygen vacancies. However, Djusiric et al.

Lancet Infect Dis 2011, 11:671–676 PubMed 7 Paton AW, Paton JC:

Lancet Infect Dis 2011, 11:671–676.PubMed 7. Paton AW, Paton JC: Escherichia coli Subtilase Cytotoxin. Toxins (Basel) 2010, 2:215–228.CrossRef 8. Paton AW, Srimanote P, Talbot UM, Wang H, Paton JC: A new family of potent AB(5) cytotoxins produced by Shiga toxigenic Escherichia coli . J Exp Med 2004,

200:35–46.find protocol PubMedCrossRef 9. Tsutsuki H, Yahiro K, Suzuki K, Suto A, Ogura K, Nagasawa S, Ihara H, Shimizu T, Nakajima H, Moss J, et al.: Subtilase cytotoxin enhances Escherichia coli survival in macrophages by suppression of nitric oxide production through the inhibition of NF-kappaB activation. Infect Immun 2012, 80:3939–3951.PubMedCrossRef 10. Paton AW, Beddoe T, Thorpe CM, Whisstock JC, Wilce MC, Rossjohn J, Talbot UM, Paton JC: AB5 subtilase cytotoxin inactivates the endoplasmic reticulum chaperone BiP. Nature 2006, 443:548–552.PubMedCrossRef 11. May KL, Paton JC, Paton AW: ARRY-438162 in vivo Escherichia coli subtilase cytotoxin induces apoptosis regulated by host

Bcl-2 family proteins Bax/Bak. Infect Immun 2010, 78:4691–4696.PubMedCrossRef 12. Wang H, Paton JC, Paton AW: Pathologic changes in mice induced by subtilase cytotoxin, a potent new Escherichia coli AB5 toxin that targets the endoplasmic reticulum. J Infect Dis 2007, 196:1093–1101.PubMedCrossRef 13. Byres E, Paton AW, Paton JC, Lofling JC, Smith DF, Wilce MC, Talbot UM, Chong DC, Yu H, Huang S, et al.: Incorporation SB202190 of a non-human glycan mediates human susceptibility to a bacterial toxin. Nature 2008, 456:648–652.PubMedCrossRef 14. Lofling JC, L-gulonolactone oxidase Paton AW, Varki NM, Paton JC, Varki A: A dietary non-human sialic acid may facilitate hemolytic-uremic syndrome. Kidney Int 2009, 76:140–144.PubMedCrossRef 15. Tozzoli R, Caprioli A, Cappannella S, Michelacci V, Marziano ML, Morabito S: Production of the subtilase AB5 cytotoxin by Shiga toxin-negative Escherichia coli . J Clin Microbiol 2010, 48:178–183.PubMedCrossRef 16. Michelacci V, Tozzoli R, Caprioli A, Martinez R, Scheutz F, Grande L, Sanchez S, Morabito S: A new pathogenicity island carrying an allelic variant

of the subtilase cytotoxin is common among Shiga toxin producing Escherichia coli of human and ovine origin. Clin Microbiol Infect 2013, 19:E149-E156.PubMedCrossRef 17. Moss JE, Cardozo TJ, Zychlinsky A, Groisman EA: The selC -associated SHI-2 pathogenicity island of Shigella flexneri . Mol Microbiol 1999, 33:74–83.PubMedCrossRef 18. Sanchez S, Beristain X, Martinez R, Garcia A, Martin C, Vidal D, Diaz-Sanchez S, Rey J, Alonso JM, Herrera-Leon S: Subtilase cytotoxin encoding genes are present in human, sheep and deer intimin-negative, Shiga toxin-producing Escherichia coli O128:H2. Vet Microbiol 2012, 159:531–535.PubMedCrossRef 19. Slanec T, Fruth A, Creuzburg K, Schmidt H: Molecular analysis of virulence profiles and Shiga toxin genes in food-borne Shiga toxin-producing Escherichia coli . Appl Environ Microbiol 2009, 75:6187–6197.PubMedCrossRef 20.

PubMedCrossRef 26 Pearson WR, Lipman DJ: Improved tools for biol

PubMedCrossRef 26. Pearson WR, Lipman DJ: Improved tools for biological sequence comparison. Proc Natl Acad Sci U S A 1988, 85:2444–2448.PubMedCentralPubMedCrossRef click here 27. Punta M, Coggill PC, Eberhardt RY, Mistry J, Tate J, Boursnell C, Pang N, Forslund K, Ceric G, Clements J, Heger A, Holm L, Sonnhammer ELL, Eddy SR, Bateman A, Finn RD: The Pfam protein families database. Nucleic Acids Res 2012, Database Issue 40:D290-D301.PubMedCentralPubMedCrossRef 28. Neumann L, Spinozzi F, Sinibaldi R, Rustichelli F, Pötter M, Steinbüchel A: Binding of the major phasin, PhaP1, from Ralstonia eutropha H16 to poly(3-hydroxybutyrate) granules. J Bacteriol 2008, 190:2911–2919.PubMedCentralPubMedCrossRef

29. Schneider CA, Rasband WS, Eliceiri KW: NIH Image to ImageJ: 25 years of image analysis. Nat Methods 2012, 9:671–675.PubMedCrossRef 30. Regensburger B, Hennecke H: RNA polymerase from Rhizobium japonicum . Arch Microbiol 1983, 135:103–109.PubMedCrossRef 31. Vincent JM: A Manual for the Practical Study of Root-Nodule Bacteria. Oxford, England: Blackwell Science Publications; 1970. [International Biological Programme Handbook No. 15] Competing interests The authors declare that they have no competing interests. Authors’ contributions Conception and design of the study: KY. Acquisition of data: YT and TS.

Analysis and interpretation of data: KT. Drafting the article: KY. Revising it critically for important intellectual Staurosporine content: KT and ST. Final approval of the version to be submitted: All the co-authors. All authors read and approved the final manuscript.”
“Background Mycobacterium

tuberculosis remains a threat to global Metformin solubility dmso health despite efforts directed towards its eradication. Although several works have been done in recent years towards understanding the genetic repertoire of this organism, many of its strategies involved in virulence, pathogenesis and resistance to both host pressure and antibiotics remain elusive [1]. Mycobacterial genome has been completely sequenced for over a decade [2]. However, the functions of many of its genes are annotated based only on similarity to known proteins using automatic annotation systems. This method of function annotation can be erroneous [3, 4]. Errors in automatic function annotation to genes in bacterial genomes are well documented. They often lead to Ricolinostat misinformation that may hamper the understanding of the roles played by many bacterial genes [5–8]. Experimental characterization of additional mycobacterial proteins is needed to aid deeper understanding of the organism. Histidine phosphatase superfamily is a large family of proteins with diverse functions that are important. This superfamily comprises two branches. The larger branch consists of proteins which function in metabolic regulations, intermediary metabolism and developmental processes.

Cells were passaged every 2-3 days to maintain exponential growth

Cells were passaged every 2-3 days to maintain exponential growth. qRT-PCR analysis of miRNA-21 and TIMP3 mRNA expression Total RNA from tissue and cells were isolated using TRIzol reagent (Invitrogen) to obtain both miRNA and mRNA. For analysis of miR-21 expression, the stem-loop

RT primer, real-time PCR primes and TaqMan MGB probe were designed as previously described [18]. Briefly, miRNAs were reverse transcribed into cDNAs by SuperScript II reverse transcriptase. Real-time PCR was performed using a standard TaqMan PCR protocol according to manufacturer’s protocols (Applied Biosystems), and learn more Relative expression was calculated using the ΔCT method and normalized to the expression Etomoxir purchase of U6 RNA. Relative levels of TIMP3 mRNA were examined by SYBR green real-time quantitative

reverse transcription-PCR (qRT-PCR) (Applied Biosystems) and normalized to β-actin mRNA. click here The primers for TIMP3 were: forward primer 5′-AGTTACCCAGCCCTATGA-3′, reverse primer 5′-GCAAAGGCTTAAACATCT-3′. All qRT-PCRs were performed in duplicate, and the data are presented as mean ± standard error of the mean (SEM). Oligonucleotide transfections For miR-21 knockdown, cells were transfected with 50 nM of oligonucleotide with Lipofectamine 2000 (Invitrogen), according to the manufacturer’s protocol. The sequences used were: 5′-UCAACAUCAGUCUGAUAAGCUA-3′ (anti-miR-21 oligonucleotide); and 5′-CAGUACUUUUGUAGUACAA-3′ (control oligonucleotide). For miR-21 overexpression, cells were transfected with a synthetic RNA duplex sequence corresponding Aspartate to mature miR-21. The sequences were: 5′-UAGCUUAUCAGACUGAUGUUGA-3′ (miR-21 oligonucleotide); and 5′-UUCUCCGAACGUGUCACGUTT-3′ (control oligonucleotide). All oligonucleotides were synthesized by Genepharma Co.

Ltd. The sequences of the control oligonucleotides were analyzed by BLAST search to exclude potential hits in the human transcriptome. Migration assay BCAP-37, MCF-7, MDA-MB-231, and MDA-MB-435 cells were transfected with anti-miR-21, miR-21, or control oligonucleotide, cultured for 48 h, and transferred onto the top of matrigel-coated invasion chambers (24-well insert, 8 μm pore size; BD Biosciences) in a serum-free DMEM. DMEM containing 10% fetal calf serum was added to the lower chamber as a chemoattractant. After 20 h incubation, non-migrated cells were removed from the inner part of the insert with a cotton swab. Fixation and staining of migrated cells were performed using 0.1% crystal violet. Cells were quantified by fluorescence microscopy (100×). Western blot analysis Cell lysates were prepared in lysis buffer (0.15 M NaCl,50 mM Tris-Cl(pH7.5), 2 mM EDTA, 0.5%Triton-100, 5 mM DTT, 0.

Figure 1 Basic data set to be filled by partners institutions

Figure 1 Basic data set to be filled by partners institutions

of DSpace ISS. Figure 2 List of some communities created ATM Kinase Inhibitor clinical trial in DSpace ISS. Referring to future initiatives, creating a workflow of data between DSpace ISS and the system run by the Italian Ministry of Health would mean to move forward the realization of a permanent free access point to the national scientific output, thus providing tools for a multidimensional evaluation of the resources produced. In this way, Italy could find its place within the context of the European countries which are investigating advanced management systems of research results. A survey of oncological IRCSS publications managing system In March 2010 a questionnaire was administered to nine Italian cancer research institutes “”Istituti di Ricovero e Cura a Carattere Scientifico”"

(IRCCS) acting in the field of oncology. These institutions are devoted to biomedical research to the benefit of the patients and to the medical community. They are: Istituto Tumori Giovanni Paolo II, Selleck A-1210477 Bari; Istituto Europeo di Oncologia, Milan; learn more Fondazione Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan; Istituto Nazionale per la Ricerca sul Cancro, Genoa; Istituto Regina Elena, Rome; Centro di Riferimento Oncologico, Aviano; Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture; Istituto Nazionale Tumori Fondazione Giovanni Pascale, Neaples; Istituto Oncologico Veneto, Padua. The questionnaire was e-mailed to Inositol monophosphatase 1 the librarians of each institution.

The survey was basically intended to identify: the archive holdings (type of research outputs contained in institutional repositories) and the system in use to support archive operations (software or paper-based system). Such information would serve the purpose of providing a baseline to explore the feasibility of a standardized workflow of data from partners joining DSpace ISS. In the subject area of oncology, the Italian research institutions surveyed in this study represent a privileged point to go in depth with the analysis of strategies to collect and disseminate relevant information to the benefit of both the scientists and the general public. Results Responding institutions The respondent institutions were six out of nine and precisely: Istituto Europeo di Oncologia, Milano; Istituto Regina Elena, Roma; Centro di Riferimento Oncologico, Aviano; Centro di Riferimento Oncologico della Basilicata, Rionero in Vulture; Istituto Nazionale Tumori Fondazione Giovanni Pascale, Neaples; Istituto Oncologico Veneto, Padua.

Melanoma cells heterogeneously express IL-18 receptors and consis

Melanoma cells heterogeneously express IL-18 receptors and consistent with its potential prometastatic action, we reported that experimental melanoma metastases are prevented in both ICE-deficient mice lacking secreted IL-18 and IL-18-binding protein-treated mice. Moreover, see more IL-18 promotes melanoma metastasis at multiple steps, including stimulating the capillary arrest of circulating tumor cells, immune escape, angiogenesis, and tumor cell proliferation. However, at the moment, the molecular mechanisms underlying IL-18-dependent

melanoma metastasis have not been elucidated. The aim of this study was to identify molecular mediators of IL-18 by exploring the melanoma cell gene display induced by this cytokine. We compared global gene expression between untreated and IL-18-treated melanomas using a high-throughput human 36 K cDNA microarray platform. Total RNA from four primary cultured human melanoma cell p38 protein kinase lines was used: two VLA-4-expressing highly-metastatic cell lines (A375 and 1182 melanoma), and two non-VLA-4

expressing low metastatic cell lines (526 and 624-28 melanoma). Gene profile was determined by cDNA microarray and real-time PCR. We found around 50 genes over-expressed (ANOVA, p < 0.05) in IL-18-treated highly metastatic versus low-metastatic melanoma cells. Some of these genes were also co-expressed by effect of soluble VCAM-1 on highly metastatic but not O-methylated flavonoid on low-metastatic melanoma cells. None of these genes were expressed by melanoma patients that did not metastasize to distant

sites within 4 years after diagnosis, while majority of them were expressed in melanomas associated with high risk of metastasis and death. In summary, we identified the biological and GDC-0994 clinical relevance of IL-18-dependent genes for highly metastatic VLA-4-expressing human melanoma, and suggest molecular pathways relevant to melanoma metastasis in the inflammatory microenvironment of IL-18. O30 Interleukin-8 Expression is Regulated by Histone Deacetylases through NF-kB Pathway in Breast Cancer Carine Chavey1, David Vindireux1, Carine Bossard1, Marcus Muehlbauer2, Christian Jorgensen1, Christian Jobin2, Gwendal Lazennec 1 1 U844, INSERM, Montpellier, France, 2 Department of Medicine, Pharmacology and Center for Gastrointestinal Biology and Disease, University of North Carolina, Chapel Hill, NC, USA We have recently reported that IL-8/CXCL8 was overexpressed in invasive estrogen receptor (ERalpha)-negative breast cancer cells, compared to ERa-positive breast cancer cells. We now demonstrate that histone deacetylases (HDAC) play an essential role in the regulation of IL-8 gene expression in ERalpha-positive MCF-7 breast cancer cells. Treatment of MCF-7 cells with the HDAC inhibitor trichostatin A (TSA) led to a strong up-regulation of IL-8 protein and RNA levels in MCF-7 cells.

Acknowledgment The author acknowledges the financial support from

Acknowledgment The author acknowledges the financial support from the National Natural Science Lazertinib in vitro Foundation of China under

grant number 61076102 and Natural Science Foundation of Jiangsu Province under grant number BK2012614. References 1. Szkutnik PD, Karmous A, Bassani F, Ronda A, Berbezier I, Gacem K, Hdiy AE, Troyon M: Ge nanocrystals formation on SiO2 by dewetting: application to memory. Eur Phys J Appl Phys 2008, 41:103.CrossRef 2. Hdiy AE, Gacem K, Troyon M, Ronda A, Bassani F, Berbezier I: Germanium nanocrystal density and size effects on carrier storage and emission. J Appl Phys 2008, 104:063716.CrossRef 3. Akca IB, Dâna A, Aydinli A, Turan R: Comparison of electron and hole charge–discharge dynamics in germanium nanocrystal check details flash memories. Appl Phys Lett 2008, 92:052103.CrossRef 4. Niquet YM, Allan G, Delerue C, Lannoo M: Quantum confinement in germanium nanocrystals. Appl Phys Lett 2000, 77:1182.CrossRef 5. Weissker H-C, Furthmüller J, Bechstedt F: Optical properties of Ge and Si nanocrystallites Selinexor mw from ab initio calculations. II. Hydrogenated nanocrystallites. Phys Rev B 2002, 65:155328.CrossRef 6. Gacem K, Hdiy AE, Troyon M, Berbezier I, Szkutnik PD, Karmous A, Ronda A: Memory and Coulomb blockade effects in germanium nanocrystals embedded in amorphous silicon on silicon

dioxide. J Appl Phys 2007, 102:093704.CrossRef 7. Yang M, Chen TP, Wong JI, Ng CY, Histone demethylase Liu Y, Ding L, Fung S, Trigg AD, Tung CH, Li CM: Charge trapping and retention behaviors of Ge nanocrystals distributed in the gate oxide near the gate synthesized by low-energy ion implantation. J Appl Phys 2007, 10:124313.CrossRef 8. Mao LF: The quantum size effects on the surface potential of nanocrystalline silicon thin film transistors. Thin Sol Films 2010, 518:3396.CrossRef 9. Mao LF: Effects of the size of silicon grain on the gate-leakage current in nanocrystalline silicon thin-film transistors. J Vac Sci Technol

2010, 28:460.CrossRef 10. Ando Y, Itoh T: Calculation of transmission tunneling current across arbitrary potential barriers. J Appl Phys 1987, 61:1497.CrossRef 11. Adikaari AADT, Carey JD, Stolojan V, Keddie JL, Silva SRP: Bandgap enhancement of layered nanocrystalline silicon from excimer laser crystallization. Nanotechnology 2006, 17:5412.CrossRef 12. Yue G, Kong G, Zhang D, Ma Z, Sheng S, Liao X: Dielectric response and its light-induced change in undoped a-Si:H films below 13 MHz. Phys Rev B 1998, 57:2387.CrossRef 13. Matsuura H, Okuno T, Okushi H, Tanaka K: Electrical properties of n-amorphous/p-crystalline silicon heterojunctions. J Appl Phys 1984, 55:1012.CrossRef Competing interest The author declares that he has no competing interest.

Osteoporos Int 20:703–714PubMedCrossRef 3 Haentjens P, Magaziner

Osteoporos Int 20:703–714PubMedCrossRef 3. Haentjens P, Magaziner J, Colon-Emeric CS et al (2010) Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med 152:380–390PubMed 4. Leslie WD, O’Donnell S, Jean S et al (2009) Trends in hip fracture rates in Canada. JAMA 302:883–889PubMedCrossRef 5. Wiktorowicz ME, Goeree R, Papaioannou A et al (2001) Economic implications of hip fracture: health service use, institutional care and cost in Canada. Osteoporos Int 12:271–278PubMedCrossRef 6. Leslie WD, Metge CJ, Azimaee M et al (2011) Direct costs of fractures in Canada and trends 1996-2006: a population-based cost-of-illness analysis.

J Bone Miner Res 26:2419–2429PubMedCrossRef 7. Bessette L, Jean S, Lapointe-Garant MP, et al. (2012) Direct medical costs attributable to peripheral fractures in Canadian PF-01367338 manufacturer post-menopausal women. Osteoporos Int 23:1757–1768 8. Jacobs P, Yim R (2009) Using Canadian administrative databases to derive economic data for health technology assessments. Canadian Agency for Drugs and Technologies in Health (CADTH), Ottawa 9. Juurlink D, Preyra C, Croxford R et al (2006) Canadian institute for health information discharge abstract database: a validation study. In ICES investigative report. Institute for

Clinical Evaluative Sciences, Toronto 10. Ray WA, Griffin MR, Fought RL et al (1992) Identification of fractures from computerized medicare files. J Clin Epidemiol 45:703–714PubMedCrossRef aminophylline 11. Williams JI, Young W (1996) Appendix 1: a summary of studies on the quality of health care administrative databases in Canada. Screening Library screening In: Goel V, Williams JI, Anderson GM, Blackstein-Hirsch P, Fooks C, Naylor CD (eds) Patterns of health care in Ontario. The ICES Practice Atlas. Canadian Medical Association, Ottawa

12. The Johns Hopkins University (2011) John Hopkins ACG case-mix adjustment system. Available at http://​www.​acg.​jhsph.​edu. Accessed 21 Jan 2011 13. Kralj B (2000) Measuring “rurality” for purposes of health-care planning: an empirical measure for Ontario. Ont Med Rev 33-52 14. Austin PC (2011) Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 10:150-161 15. Wodchis WP, Bushmeneva K, Nikitovic M et al (2012) BGB324 molecular weight Guidelines on person-level costing using administrative databases in Ontario. Health System Performance Research Network, Toronto 16. Pink GH, Bolley HB (1994) Physicians in health care management: 3. Case mix groups and resource intensity weights: an overview for physicians. CMAJ 150:889–894PubMed 17. Canadian Institute for Health Information (2004) Acute care grouping methodologies: from diagnosis related groups to case mix groups redevelopment 18. Canadian Institute for Health Information (2010) CCRS technical document—Ontario RUG weighted patient day (RWPD) methodology. http://​www.​cihi.